Tumor targeting via EPR: Strategies to enhance patient responses.

Advanced Drug Delivery Reviews
Susanne K GolombekTwan Lammers

Abstract

The tumor accumulation of nanomedicines relies on the enhanced permeability and retention (EPR) effect. In the last 5-10 years, it has been increasingly recognized that there is a large inter- and intra-individual heterogeneity in EPR-mediated tumor targeting, explaining the heterogeneous outcomes of clinical trials in which nanomedicine formulations have been evaluated. To address this heterogeneity, as in other areas of oncology drug development, we have to move away from a one-size-fits-all tumor targeting approach, towards methods that can be employed to individualize and improve nanomedicine treatments. To this end, efforts have to be invested in better understanding the nature, the complexity and the heterogeneity of the EPR effect, and in establishing systems and strategies to enhance, combine, bypass and image EPR-based tumor targeting. In the present manuscript, we summarize key studies in which these strategies are explored, and we discuss how these approaches can be employed to enhance patient responses.

Citations

Aug 6, 2019·Chemical Communications : Chem Comm·Yu GengYouqing Shen
Aug 28, 2019·Nanoscale·Michelle MuzzioShouheng Sun
Jun 20, 2019·Small·Marco D TorelliOlga A Shenderova
Oct 1, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Usman ArshadAndrew Owen
Feb 11, 2020·Drug Delivery and Translational Research·Inés Luis de RedínJuan M Irache
Feb 6, 2020·Cancers·Milita DarguzyteFabian Kiessling
Jan 3, 2020·Photochemistry and Photobiology·Aaron J SorrinImran Rizvi
May 27, 2020·Acta Pharmacologica Sinica·Simon Van Herck, Bruno G De Geest
Jul 1, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Mohsen Khodadadi YazdiMasoud Mozafari
Dec 7, 2018·International Journal of Molecular Sciences·Min Woo KimAeju Lee
Dec 19, 2019·Journal of Hematology & Oncology·Ye ZhangTing Liu
Jan 19, 2020·Pharmaceutics·Silvia VociDonato Cosco
Mar 13, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Nicholas E Wojtynek, Aaron M Mohs
Aug 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fernando Novio
Aug 29, 2019·Nuclear Medicine and Molecular Imaging·Wooseung Lee, Hyung-Jun Im
Oct 12, 2019·F1000Research·Mary-Ann Bjornsti, Scott H Kaufmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.